A multi-national, $800 billion in assets, institutional lender engaged SCALE to advise in the restructuring of a specialty pharmacy and infusion borrower owned by a private equity firm.
The underlying company included multiple business lines serving both disparate and partially overlapping markets. Each business line had a unique strategic and financial profile, as well as varying levels of reliance on shared corporate infrastructure.
Our client sought to assess various alternatives:
1. Identify strong performing portions of the business and migrate out of weak portions of the business.
2. Sale of all or a portion of the business.
3. Pursue a partial or full liquidation.
4. Pursue an in-court restructuring.
SCALE delivered a detailed assessment report and provided on-going advisory and analytics to support our client’s evaluation of various paths, considerations and potential outcomes.
Connect with us to explore how our trusted solutions can help you reach your goals. Fill out the form below, and a member of our team will follow up with personalized details for your organization.